Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 627, pseudogene (RN7SL627P)

Target
RN7SL627P
Molecular classification
Pseudogene, Non-coding RNA, 7SL RNA family
01

Overview

RNA, 7SL, cytoplasmic 627, pseudogene (RN7SL627P) is a human pseudogene derived from the 7SL RNA gene, which normally encodes the RNA component of the signal recognition particle (SRP) essential for protein targeting to the endoplasmic reticulum[1][3][5]. The genomic sequence of RN7SL627P is characterized as a truncated, nonfunctional remnant of 7SL RNA, lacking the capacity to be processed into a biologically active SRP RNA molecule[1][5]. Pseudogenes of the 7SL RNA are abundant in the human genome and generally arise by reverse transcription and genomic integration of RNA transcripts, but do not encode proteins or functional RNAs[1][5]. There is no evidence that RN7SL627P acts as a therapeutic target, encodes a functional product, contributes to specific biological processes, or has any clinical, disease, or drug-interacting relevance[1][5]. While rare examples of pseudogene regulatory activity exist for other pseudogenes, there is no data indicating such functions for RN7SL627P[1][2][4]. The listing of this locus as a target is incorrect; it is not a receptor, enzyme, or other druggable molecule, and should not be categorized as a therapeutic target[1].

Other names
RN7SL627PRNA 7SL cytoplasmic 627 pseudogene
02

Mechanism of action

None

03

Biological functions

None (no known biological activity; pseudogene)
04

Disease associations

None (no recognized disease role; pseudogene status)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 627, pseudogene (RN7SL627P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 627, pseudogene (RN7SL627P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call